Severe prolongation of the INR in spur cell anemia of cirrhosis: True-true and related?

Digestive Diseases and Sciences

Volumn 51, Issue 7, 2006, Pages 1203-1205

  Sundaram, Vinay ^a   Al Osaimi, Abdullah M S ^a   Lewis, Jason J ^a   Lisman, Ton ^b   Caldwell, Stephen H ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Acanthocytosis; Bleeding risk; Coagulopathy; Liver disease

Indexed keywords

PROTHROMBIN; THROMBOPLASTIN; VITAMIN K GROUP; WARFARIN;

ABDOMINAL RADIOGRAPHY; ACCURACY; ADULT; ANAMNESIS; ANEMIA; ANTICOAGULATION; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LABORATORY TEST; LIVER CIRRHOSIS; LIVER HEMORRHAGE; PRIORITY JOURNAL; PROGNOSIS; PROTHROMBIN TIME; RISK; SPUR CELL ANEMIA; THROMBOCYTE COUNT;

ADULT; ANEMIA; BIOLOGICAL MARKERS; BLOOD COAGULATION FACTORS; FATAL OUTCOME; FEMALE; HEPATORENAL SYNDROME; HUMANS; INTERNATIONAL NORMALIZED RATIO; LIVER CIRRHOSIS, ALCOHOLIC; LIVER FAILURE; PROTHROMBIN TIME;

EID: 33748432983     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-8033-8     Document Type: Article

References (18)

1. WHO Expert Committee on Biological Standardization: 33rd Report. Technical Report Series No. 687. Geneva, Switzerland, World Health Organization, 1983
2. Hirsh J, Poller L: The international normalized ratio. A guide to understanding and correcting its problems. Arch Intern Med 154:282-288, 1994
3. Hirsh J: Oral anticoagulant drugs. N Engl J Med 324:1865-1875, 1991
4. Ewe K: Bleeding after liver biopsy does not correlate with indices of peripheral coagulation. Dig Dis Sci 26:388-393, 1981
5. Boks AL, Brommer EJ, Schalm SW, Van Vliet HH: Hemostasis and fibrinolysis in severe liver failure and their relation to hemorrhage. Hepatology 6:79-86, 1986
6. Robert A, Chazouilleres O: Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio. Hepatology 24:1392-1394, 1996
7. Kovacs MJ, Wong A, MacKinnon K, Weir K, Keeney M, Boyle E, Cruickshank M: Assessment of the validity of the INR system for patients with liver impairment. Thromb Haemost 71:727-730, 1994
8. Trotter JF, Brimhall B, Arjal R, Phillips C: Specific laboratory methodologies achieve higher Model for End-stage Liver Disease (MELD) scores for patients listed for liver transplantation. Liver Transpl 10:995-1000, 2004
9. Caldwell SH, Chang C, Macik BG: Recombinant activated factor VII (rFVIIa) as a hemostatic agent in liver disease: A break from convention in need of controlled trials. Hepatology 39:592-598, 2004
10. Veldman A, Hoffman M, Ehrenforth S: New insights into the coagulation system and implications for new therapeutic options with recombinant factor VIIa. Curr Med Chem 10:797-811, 2003
11. Chitale AA, Sterling RK, Post AB, Silver BJ, Mulligan DC, Schulak JA: Resolution of spur cell anemia with liver transplantation: A case report and review of the literature. Transplantation 65:993-995, 1998
12. Cooper RA, Milagros DP, Lando P, Greenverg MS: An analysis of lipoproteins, bile acids, and red cell membranes associated with target cells and spur cells in patients with liver disease. J Clin Invest 51:3182-3192, 1972
13. Doll DC: Surface morphology of platelets in spur-cell anemia. Hum Pathol 13:671-672, 1982
14. Ulibarrena C, Vecino A, Cesar JM: Red cell lipid abnormalities in acquired acanthocytosis are extended to platelets. Br J Haematol 87:614-616, 1994
15. Shattil SJ, Anaya-Galindo R, Bennett J, Colman RW, Cooper RA: Platelet hypersensitivity induced by cholesterol incorporation. J Clin Invest 55:636-643, 1975
16. Smeets EF, Comfurius P, Bevers EM, Zwaal RF: Contribution of different phospholipid classes to the prothrombin converting capacity of sonicated lipid vesicles. Thromb Res 81:419-426, 1996
17. Watanabe M, Shiraishi K, Itakura M, Matsuzaki S: Relationship between platelet membrane lipid compositions and platelet aggregability in alcoholic liver disease. Alcohol Clin Exp Res 22(Suppl 3):97S-102S, 1998
18. Zieve L: Jaundice, hyperlipidemia and hemolytic anemia: A heretofore unrecognized syndrome associated with alcoholic fatty liver and cirrhosis. Ann Intern Med 48:471-496, 1958